Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-03

FDA Approved: TRAVOPROST — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp. for Travoprost (ophthalmic) under an ANDA, granting additional regulatory clearance for this generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost (Travoprost (isomer-free))

Snippet

SUPPL AP for TRAVOPROST (TRAVOPROST)